Tirzepatide Prescribing at CULVERHAY SURGERY
Drugs used in diabetes | Endocrine System
Items (12m)
921
Total Quantity
929
NHS Cost
£86.9K
vs National Avg
+374.2%
CULVERHAY SURGERY prescribed 921 items of Tirzepatide over the last 12 months at a cost of £86,934 to the NHS. This is 374.2% above the national average prescribing rate. Tirzepatide is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jul 2026
31
Jul 2026
36
Jul 2026
56
Jul 2026
51
Jul 2026
64
Jul 2026
86
Jul 2026
87
Jul 2026
95
Jul 2026
110
Jul 2026
92
Jul 2026
110
Jul 2026
103
Prescribing Details
| Total Items | 921 |
|---|---|
| Total Quantity | 929 |
| Total NHS Cost | £86,934 |
| Presentations | 10 different forms |
| vs National Average | +374.2% |
Tirzepatide Prescribing Comparison
| This practice | 921 items |
|---|---|
| National average per practice | 194 items |
| Difference | +374.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.